Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes
about
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitusDiabetes drugs and the incidence of solid cancers: a survey of the current evidence.Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial).Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy in Type 2 Diabetes: A Primary Care Database Study.Sodium-glucose co-transporter-2 inhibitors and risk of adverse renal outcomes among patients with type 2 diabetes: A network and cumulative meta-analysis of randomized controlled trials.Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes.Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study.Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function
P2860
Q26782225-50C5B7B8-CD02-4C87-ACB8-09C3621AEB2BQ38651175-F8EB0CEA-B66B-4472-A2B1-3BD2972AA6A2Q38737540-4A2DA992-DBC5-48DA-9506-6818A665BBC0Q38903825-FEF046B1-4F42-4144-9A24-A0AABBF78917Q38940175-05006557-7A96-425D-BB56-22A019DAF307Q39170860-28DB1DEC-FF2D-4547-9E87-49589B5C9B04Q41678361-0BC1013F-D98F-444F-8682-F4F7A267D5F6Q58780047-2D5BF618-1377-46FF-A572-EB18D79FA10B
P2860
Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes
@ast
Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes
@en
type
label
Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes
@ast
Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes
@en
prefLabel
Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes
@ast
Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes
@en
P2860
P356
P1476
Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes
@en
P2093
Deborah Hinnen
P2860
P304
P356
10.1177/2042018815575273
P577
2015-06-01T00:00:00Z